Revenue by Geography
Rest of World Revenue
+1.46%
+15.6%
Other North American Operations (NAO) Revenue
-1.48%
-13.82%
China Revenue
-3.27%
-28.32%
Revenue
Ozempic Revenue
+1.62%
+17.45%
Victoza Revenue
+3.77%
+44.73%
Total Obesity Care Revenue
-0.17%
-1.68%
Rybelsus Revenue
-0.9%
-8.61%
Rare Disease Revenue
+1.2%
+12.7%
Other Diabetes Care Revenue
+1.45%
+15.43%
EBIT
Diabetes & Obesity Care Operating Profit
-0.88%
-8.46%
Rare Disease Operating Profit
-1.56%
-14.59%
